ALLADAPT IMMUNOTHERAPEUTICS
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being advanced as a broad spectrum oral immunotherapy treatment to mitigate food allergy triggered by single or multiple proteins from an expansive set of common allergens.
ALLADAPT IMMUNOTHERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.alladapt.com
Total Employee:
11+
Status:
Active
Total Funding:
229 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 50m
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Alladapt Immunotherapeutics
WestRiver Group
WestRiver Group investment in Venture Round - Alladapt Immunotherapeutics
Gurnet Point Capital
Gurnet Point Capital investment in Venture Round - Alladapt Immunotherapeutics
Novartis
Novartis investment in Venture Round - Alladapt Immunotherapeutics
Patient Square Capital
Patient Square Capital investment in Venture Round - Alladapt Immunotherapeutics
Red Tree Venture Capital
Red Tree Venture Capital investment in Venture Round - Alladapt Immunotherapeutics
AllerFund
AllerFund investment in Venture Round - Alladapt Immunotherapeutics
TRB Advisors
TRB Advisors investment in Series C - Alladapt Immunotherapeutics
Jeff Weiner
Jeff Weiner investment in Series C - Alladapt Immunotherapeutics
Sacha Lainovic
Sacha Lainovic investment in Series C - Alladapt Immunotherapeutics
Official Site Inspections
http://www.alladapt.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.01 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Alladapt Immunotherapeutics"
Alladapt Immunotherapeutics
Alladapt was co-founded in 2018 in Palo Alto, California, by allergist and protein biochemist Kari Nadeau, MD, PhD, and biotechnology entrepreneur, Ashley Dombkowski, PhD. ... Switzerland …See details»
Alladapt Immunotherapeutics - Org Chart, Teams, Culture & Jobs
View Alladapt Immunotherapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Alladapt Immunotherapeutics - Crunchbase
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is …See details»
Org Chart Alladapt Immunotherapeutics - The Official Board
Organizational Chart of Alladapt Immunotherapeutics. Alladapt Immunotherapeutics www.alladapt.com. has 12 executives +1 650 420 3900; Add an executive. Alladapt …See details»
Alladapt Immunotherapeutics Company Profile | Management and …
Alladapt Immunotherapeutics Profile and History. Alladapt was co-founded in 2018 in Palo Alto, California, by allergist and protein biochemist Kari Nadeau, MD, PhD, and biotechnology …See details»
Alladapt Immunotherapeutics - Overview, News & Similar
May 22, 2022 Who is Alladapt Immunotherapeutics. Alladapt was co-founded in 2018 in Palo Alto, California, by allergist and protein biochemist Kari Nadeau, MD, PhD, and biotechnology …See details»
Alladapt Immunotherapeutics - Contacts, Employees, Board …
Organization. Alladapt Immunotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Alladapt Immunotherapeutics has …See details»
Alladapt Immunotherapeutics - Updates, News, Events, Signals
Alladapt Immunotherapeutics may be growing as it has received FDA Fast Track Designation for ADP101, which is a significant regulatory milestone that can expedite the development and …See details»
ALLADAPT IMMUNOTHERAPEUTICS, INC. - Dun & Bradstreet
Alladapt immunotherapeutics, inc. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / …See details»
Alladapt Immunotherapeutics - Overview, News & Competitors
Alladapt Immunotherapeutics - Business Information. Business Services · California, United States · <25 Employees. Alladapt Immunotherapeutics Inc is a company that operates in the …See details»
Alladapt Press Release 22 April 2021
Alladapt Immunotherapeutics is a private, clinical-stage biopharmaceutical company developing prescription therapeutics targeting food allergy. Alladapt was co-founded in 2018 by allergist …See details»
Alladapt Immunotherapeutics
Alladapt was co-founded in 2018 in Palo Alto, California, by allergist and protein biochemist Kari Nadeau, MD, PhD, and biotechnology entrepreneur, Ashley Dombkowski, PhD. Academic …See details»
Alladapt Immunotherapeutics Company Profile - Craft
Alladapt Immunotherapeutics is a biopharmaceutical company developing prescription therapies in the field of food allergy. It offers ADP101, a broad spectrum oral immunotherapy treatment …See details»
Alladapt Immunotherapeutics Company Profile: Overview and Full …
Alladapt Immunotherapeutics, based in California, is dedicated to developing and commercializing effective interventions for food allergy. The company's focus is on the development of …See details»
Alladapt - Company Profile - Tracxn
Oct 22, 2024 Alladapt ranks 20th among 148 active competitors. 59 of its competitors are funded while 28 have exited. Overall, Alladapt and its competitors have raised over $5.18B in funding …See details»
Alladapt Immunotherapeutics - Funding, Financials, Valuation
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. Search Crunchbase. ... How much funding has …See details»
Alladapt: addressing multiple food allergies simultaneously
Apr 8, 2022 Alladapt is creating an oral immunotherapy comprising proteins from multiple food allergens and hoping that gradually increasing the dose will desensitize the immune system. …See details»
Alladapt Announces Positive Results for Multi-Allergen OIT …
Jun 14, 2023 Yesterday, Alladapt Immunotherapeutics — a privately held biopharma company based in Menlo Park, CA — presented topline results of their Phase 1/2 study of ADP101 at …See details»
Alladapt Immunotherapeutics - VentureRadar
Alladapt Immunotherapeutics Inc., is a private, clinical-stage biopharmaceutical company developing prescription therapeutics targeting food allergy. The company is currently …See details»
Alladapt's 15-allergen drug desensitizes kids to multiple foods
Jun 13, 2023 California-based Alladapt has hoovered up money in recent years, raising $119 million in 2022 to add to the $60 million it secured in 2020 on the strength of its vision for …See details»